U.S. stock futures are pointing lower as investors review comments from China that accused the U.S. of undermining the recent ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Blueprint Medicines Corporation to Sanofi is fair to Blueprint shareholders. Under the terms of the proposed ...

The deal includes a drug approved in the U.S. and the EU for systemic mastocytosis, a rare immunology disease, as well as an ...

Regeneron Pharmaceuticals declined by 16.7 percent last week as investors sold off positions amid the surprising failure of ...

S&P 500 E-Mini futures (ESM25) are down -0.57%, andJune Nasdaq 100 E-Mini futures (NQM25) are down -0.69% this ...